Pacific Biosciences of California, Inc.
PACB· Nasdaq
PACBPacific Biosciences of California, Inc.
Released Nov 2, 2021, after the close
10-Q filed Nov 5, 2021, 36 days after period end · 0001299130-21-000216
| Metric | Q3 2021 | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|---|
| Revenue | $34.89M | $19.08M | $21.92M | $18.16M |
| Net Income | $16.54M | -$23.71M | -$29.12M | -$25.04M |
| EPS Diluted |
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
| $0.08 |
| -$0.14 |
| -$0.19 |
| -$0.19 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
